Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sodium cromoglicate plus nasal glucocorticoid for drug-induced rhinitis
ChiCTR2100050716Phase 4Recruiting
- Sponsor
- Yantai Yuhuangding Hospital
- Start
- Sep 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of sodium cromoglycate and mometasone in Drug-induced rhinitis (DIR) (3 arms), sponsored by Yantai Yuhuangding Hospital. Primary endpoints: Nasal endoscopy findings, VAS pain score and 1 more. Started Sep 2021; status: recruiting.
02
Drugs
sodium cromoglycatemometasone
03
Conditions
Drug-induced rhinitis (DIR)
Beyond the preview
Go deeper on ChiCTR2100050716.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100050716.